Sabby Management’s Scinai Immunotherapeutics SCNI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-17,828
| Closed | -$49.6K | – | 49 |
|
|
2024
Q2 | $49.6K | Sell |
17,828
-7,486
| -30% | -$20.8K | 0.03% | 21 |
|
|
2024
Q1 | $131K | Buy |
25,314
+3,248
| +15% | +$16.9K | 0.08% | 22 |
|
|
2023
Q4 | $131K | Sell |
22,066
-2,431
| -10% | -$14.5K | 0.13% | 24 |
|
|
2023
Q3 | $213K | Buy |
24,497
+5,404
| +28% | +$47K | 0.16% | 29 |
|
|
2023
Q2 | $269K | Sell |
19,093
-13,504
| -41% | -$190K | 0.22% | 34 |
|
|
2023
Q1 | $704K | Buy |
32,597
+10,541
| +48% | +$228K | 0.61% | 11 |
|
|
2022
Q4 | $653K | Buy |
+22,056
| New | +$653K | 0.57% | 15 |
|
|
2017
Q4 | – | Sell |
-194
| Closed | -$139K | – | 117 |
|
|
2017
Q3 | $139K | Buy |
+194
| New | +$139K | 0.01% | 59 |
|